🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT04328038
Active, not recruiting Observational

Personalized Exercise Oncology

NCT04328038 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2018-11-26
Last updated
2025-02-03

Condition(s) studied

CancerHealth Behavior

Investigational drug(s) / intervention(s)

Survey

Survey: Patient fill out a survey containing: Demographic Information, medical history, several Questionnaires about Health Literacy, Well Being/HRQoL and Fatigue

Study summary

The Goal of the study is to identify trait-homogenous groups of cancer patients in regards to their physical activity associated health literacy. Based on these Groups, individualized exercise protocols and educative strategies can be developed which may increase the efficacy of the exercise therapy and increases the likelihood that patient get involved in physical activity.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Histologically confirmed cancer diagnosis * Females and males ≥18 years of age * Undergoing either chemo-, immune-, radio- or anti-hormonal treatment * Last surgery more than 6 weeks in the past * Ability to understand English or German * Be able to provide and understand informed consent * Have an Eastern Cooperative Oncology Group (ECOG) Performance Score of ≤ 2 Exclusion Criteria: * Heart insufficiency \> NYHA III (New York Heart Association) or uncertain arrhythmia * Uncontrolled hypertension * Severe renal dysfunction (GFR \< 30%, Creatinine\> 3mg/dl) * Reduced standing or walking * Current pregnancy * Any other evidence in the medical record of an absolute contraindication for exercise

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Heidelberg University Hospital Heidelberg Germany

More University Hospital Heidelberg trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04328038 on ClinicalTrials.gov ↗ ← All trials in Germany